Navigation Links
Baxter International Third Quarter 2008 Financial Results Conference Call
Date:9/17/2008

DEERFIELD, Ill., Sept. 17 /PRNewswire-FirstCall/ -- Baxter International (NYSE: BAX), will host a quarterly conference call to discuss its third quarter 2008 financial results on Thursday, October 16, 2008, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To access the call, please dial 866- 238-0637 (domestic) or 703-639-1156 (international). Please dial into the call at least ten minutes prior to the start of the call for the operator to connect you.

This call is being webcast by Thomson/CCBN and can be accessed at Baxter's Web site at http://www.baxter.com/. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Contact Information:

Investor Relations Contact

Mary Kay Ladone, +1-847-948-3371

Mary_Kay_Ladone@baxter.com

Clare Trachtman, +1-847-948-3085

Clare_Trachtman@baxter.com


'/>"/>
SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year
2. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
3. Baxter Declares Quarterly Dividend
4. Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
5. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
6. Baxters Board of Directors Declares Quarterly Dividend
7. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
8. Baxters V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
9. Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
10. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
11. Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016  OncoSec Medical Incorporated ("OncoSec") ... DNA-based intratumoral cancer immunotherapies, today announced financial results ... "We are delivering on our commitment to ... ImmunoPulse┬« IL-12. We are pleased with the early ... trial, and we are focused on advancing our ...
(Date:12/8/2016)... Dec. 8, 2016 Eurofins announces the appointment of ... of Eurofins Scientific Inc. (ESI). Mr. Murray will ... professional and entrepreneurial experience in leading international business teams. As the ... testing market to uphold Eurofins, status as the global leader in ... , ...
(Date:12/8/2016)... , Dec. 8, 2016  Anaconda BioMed S.L., ... development of the next generation neuro-thrombectomy system for the ... of Tudor G. Jovin, MD to join its Scientific ... as a strategic network of scientific and clinical experts ... development of the ANCD BRAIN ┬« to its ...
(Date:12/8/2016)... 2016  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... developing and commercializing products to treat rare diseases ... today the long-term follow-up data from its Phase ... Innate Defense Regulator (IDR), in the treatment of ... patients undergoing chemoradiation therapy (CRT).  The additional 12-month ...
Breaking Biology Technology:
(Date:11/22/2016)... 22, 2016 According to the new market research ... Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and ... the market is expected to grow from USD 10.74 Billion in 2015 ... between 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)...  AIC announces that it has just released a new white paper authored by ... plus high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can ...
(Date:11/14/2016)... 14, 2016  Based on its recent ... & Sullivan recognizes FST Biometrics with the ... Visionary Innovation Leadership. FST Biometrics emerged as ... market by pioneering In Motion Identification (IMID) ... seamless, and non-invasive verification. This patented solution ...
Breaking Biology News(10 mins):